Correcting a misrepresentation of Hypervitaminosis A attributed to herbalife product consumption

Experimental and Molecular Pathology

Volumn 90, Issue 3, 2011, Pages 320-321

  Bejar, Ezra ^a   Smith, Casey R ^a   Appelhans, Kristy ^a   Henig, Y Steve ^a  

^a Herbalife International ^*  (United States)

Author keywords

Hepatotoxicity; Herbalife; Hypervitaminosis A; Liver

Indexed keywords

BETA CAROTENE; HERBALIFE; MULTIVITAMIN; RETINOL; UNCLASSIFIED DRUG;

CALCULATION; DIET SUPPLEMENTATION; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; HUMAN; INTRAHEPATIC CHOLESTASIS; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MAXIMUM ALLOWABLE CONCENTRATION; RETINOL INTOXICATION;

BIOMEDICAL RESEARCH; EPHEDRA; FOOD ADDITIVES; HUMANS; HYPERVITAMINOSIS A; TREATMENT OUTCOME;

EID: 79955740264     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.02.001     Document Type: Letter

References (4)

1. Hathcock J.N. Vitamin and Mineral Safety 2004, Council for Responsible Nutrition, Washington DC. 2nd. Edition.
2. Kaplowitz N., DeLeve L.D. Drug-induced Liver Disease 2003, Marcel Dekker, Inc., New York.
3. Ramanathan V.S., Pham B.V., French S., Hensley G., Eysselein V., Chung D., Reicher S. Hypervitaminosis A inducing intra-hepatic cholestasis - a rare case report. Exp. Mol. Path. 2010, 88(2):324-325.
4. Shils, M.E., Olson, J.A., Shike, M., Ross, A.C. (Eds.), 1999. Modern nutrition in health and disease, 9th ed. Williams & Wilkins, Philadelphia.